Back

Transcriptomic profiling of dysfunctional adipose tissue defines biomarker signatures that improve diabetes risk assessment

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Adipose tissue, metabolic syndrome, and cardiometabolic disease Lipid Metabolism, Metabolic Syndrome, Diabetes ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Oliver Ian Brown

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Inflammatory epicardial adipose tissue–myocardial crosstalk in coronary artery disease: a single-cell analysis
Doctor S. Doppler (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Triple GLP-1R/GIP-R/GCGR activation synergistically suppresses macrophage-driven oxidative stress and activation in human epicardial adipose tissue from patients with a history of atrial fibrillation
Doctor W. Fakih (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Cilostazol restores endothelial function and reduces platelet hyperactivity via PKA/ENOS/PKG and NRF2 signaling in experimental metabolic syndrome
Doctor G. Lima (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Associations between glucolipid metabolic indices with the risk and progression of cardiovascular-kidney-metabolic syndrome in MASLD: evidence from the UK biobank
Mr R. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Skeletal muscle acts as a major organ for systemic oxidized LDL clearance via a CD36-dependent mechanism enhanced by physical exercise.
Professor T. Sawamura (Matsumoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Adipose tissue, metabolic syndrome, and cardiometabolic disease

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Precision Phenotyping of Multi-Organ Fat Distribution Defines Distinct Cardiorenal-Metabolic and Heart Failure Risk Profiles
31 August 2026
thumbnail
Congress Presentation
Acylcarnitines as markers of early cardiometabolic dysregulation in a population-based sample of apparently healthy adults
28 August 2026
thumbnail
Congress Presentation
Serpina3c deficiency aggravates vascular dysfunction and VSMC dysregulation through regulating adamts4 pathway activity in obese mice
1 September 2024
thumbnail
Congress Presentation
MRI-based body composition predicts incident type 2 diabetes mellitus
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources